RxDoctor Payments Data

Laura Powers

Family · Ft Wright, KYNPI 1881930915

Payments from drug & device makers

$882in general payments, 2019–2025

Across 38 payments — averaging $23.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$284
  • Atos Medical Inc$132
  • Lilly USA, LLC$97
  • Amarin Pharma, Inc.$55
  • GSK$46
  • Esperion Therapeutics, Inc.$42
  • plus $225 from 10 others

What the payments were for

  • Food & beverage$882100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$882 in reported general payments places this provider in the 60th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$89,065
Medicare patients
150
Services billed
902

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban28$12,642
TrulicityDulaglutide19$11,138
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog36$5,499
JardianceEmpagliflozin16$4,878
Meropenem12$2,528
Lantus SolostarInsulin Glargine,hum.Rec.Anlog61$2,110
Pantoprazole Sodium34$1,303
Novolog FlexpenInsulin Aspart18$907
Potassium Chloride14$755
Insulin Aspart FlexpenInsulin Aspart13$749
Lorazepam62$739
Mirtazapine28$675
Pregabalin22$618
Levofloxacin16$535
Albuterol Sulfate HfaAlbuterol Sulfate11$520

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$19$12,64228 claims
Lilly USA, LLCTrulicity$97$11,13819 claims
Boehringer IngelheimJardiance$35$4,87816 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 4,374 family providers in Kentucky.

Other family in Ft Wright

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →